Literature DB >> 3167779

Risk factors for varicella zoster disseminated infection among adult cancer patients with localized zoster.

J J Rusthoven1, P Ahlgren, T Elhakim, P Pinfold, L Stewart, R Feld.   

Abstract

Varicella zoster (VZ) infection can be a highly morbid and potentially fatal disease among immunocompromised patients; 811 episodes of VZ infection among adult cancer patients seen at the Princess Margaret Hospital from 1970 to 1980, were identified. Seven hundred twelve patients with first episodes of localized VZ infection (zoster) were analyzed for potential risk factors for dissemination. Significant risk factors after univariate analysis included the diagnosis of Hodgkin's disease, decreasing age, chemotherapy within 6 months of VZ infection, and extensive tumor at initial tumor diagnosis. Complete tumor remission at the time of infection, previous radiotherapy, and breast or gynecologic cancer were associated with reduced risk in this analysis. After multivariate analysis the following factors were independently associated with increased risk: Hodgkin's disease (P less than 0.001), non-Hodgkin's lymphoma (P = 0.016), and head and neck cancer (P = 0.043). Complete tumor remission and previous radiotherapy were again related to a reduced risk of infection. This study identifies risk factors that define specific subgroups of adult cancer patients with zoster infections who are at increased risk for VZ dissemination. These factors may be useful in prospectively defining high-risk groups in the design of antiviral therapy trials and may have a role in deciding which cancer patients with zoster will benefit most from receiving antiviral therapy to prevent dissemination.

Entities:  

Mesh:

Year:  1988        PMID: 3167779     DOI: 10.1002/1097-0142(19881015)62:8<1641::aid-cncr2820620831>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

Review 1.  [Varicella-zoster virus infections].

Authors:  H M Lilie; S W Wassilew
Journal:  Hautarzt       Date:  2004-09       Impact factor: 0.751

Review 2.  Recognition and treatment of shingles.

Authors:  A F Nikkels; G E Piérard
Journal:  Drugs       Date:  1994-10       Impact factor: 9.546

3.  Herpes simplex virus 1 infection on a reconstructive free flap.

Authors:  Simon P Parys; Thea Leman; Reuven Gurfinkel
Journal:  Eplasty       Date:  2013-06-04

4.  The great mimicker: zona zoster at the mastectomy site causing contralateral intramammary lymph node enlargement.

Authors:  Umit Aksoy Ozcan; Evrim Tezcanli; Yesim Yildirim; Melahat Garipagaoglu
Journal:  Case Rep Oncol Med       Date:  2012-03-15

5.  Radiotherapy combined with chemotherapy increases the risk of herpes zoster in patients with gynecological cancers: a nationwide cohort study.

Authors:  Peng Yi Lee; Jung Nien Lai; Shang Wen Chen; Ying Chun Lin; Lu Ting Chiu; Yu Ting Wei
Journal:  J Gynecol Oncol       Date:  2020-12-02       Impact factor: 4.401

Review 6.  Safety Profile of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Populations: An Overview of Six Trials.

Authors:  Marta López-Fauqued; Maribel Co-van der Mee; Adriana Bastidas; Pierre Beukelaers; Alemnew F Dagnew; Juan Jose Fernandez Garcia; Anne Schuind; Fernanda Tavares-da-Silva
Journal:  Drug Saf       Date:  2021-06-11       Impact factor: 5.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.